Thursday, July 23, 2026

Lunit Scope: How AI Biomarkers Are Revolutionizing Cancer Treatment at AACR 2026

Lunit to present six AI biomarker studies at AACR 2026, showcasing advancements in cancer treatment and AI technology.

A Glimpse Into the Minds of Literary Legends: Their Picks for the Century’s Best

Anticipation is mounting over whether Min Jin...

North Korea’s Nampo Port Sees Steady Flow of Large Ships as Coal Smuggling Allegations Grow

North Korea's Nampo Port sees frequent large vessels, raising concerns over illicit coal exports despite UN sanctions.

Tag: Lunit

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

Lunit Joins Nvidia AI Ecosystem Meeting to Explore Global Healthcare AI Partnerships

Lunit, a medical AI firm, will attend NVIDIA's AI Ecosystem meeting in Seoul, following CEO Jensen Huang's visit.

Lunit to Present Five AI Biomarker Studies at ASCO 2026 Highlighting Expanded Clinical Applications

Lunit will present five AI studies at ASCO 2026, showcasing biomarker analysis for cancer treatment and patient response prediction.

NCCN Adds Imaging-Based Breast Cancer Risk Assessment, Opening New Path for AI Screening Tools

Lunit's AI tool for breast cancer risk assessment gains recognition in NCCN guidelines, enhancing early detection and personalized management.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Lunit supplies integrated breast cancer diagnostic solution to Lexington Clinic

Lunit supplies integrated breast cancer AI solutions to Lexington Clinic, enhancing diagnostics and expanding its presence in the Americas.

Lunit’s 200 Billion KRW Funding: How Atinum Investment Boosts AI in Healthcare

Lunit secures 30 billion KRW investment from Atinum to enhance global R&D and operations, reinforcing its position in medical AI.

Lunit’s AI Innovations: How a Meeting with France’s SGPI Could Transform Healthcare

Lunit discusses collaboration with France's SGPI to enhance medical AI technology in public healthcare, aligning with a strategic partnership.

Lunit’s AI Foundation Model: Transforming Healthcare with 16 Billion Parameters

Medical AI firm Lunit successfully passes the first phase of a national project and enters the second phase of nationwide validation.

AI in Healthcare: How Lunit and KAIST Are Revolutionizing Medical Technology in 2026

South Korea enhances AI in healthcare with Lunit and KAIST's models, achieving high accuracy and speed for medical applications.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

Lunit Scope: How AI Biomarkers Are Revolutionizing Cancer Treatment at AACR 2026

Lunit to present six AI biomarker studies at AACR 2026, showcasing advancements in cancer treatment and AI technology.

How Lunit’s AI is Transforming Early Breast Cancer Risk Assessment: Key Findings from ECR 2026

Lunit presents 21 research findings at ECR 2026, showcasing AI's potential in breast cancer risk assessment and screening innovations.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.